Abstract
To the Editor:— Since 1957 the monoamine oxidase (MAO) inhibitors have been widely used in the treatment of depression, despite conflicting studies regarding their effectiveness. The adverse reactions associated with these drugs have been many and serious. 1 Particularly disquieting are the reports of hypertensive crises and intracranial bleeding when MAO inhibitors are used in conjunction with various sympathomimetic amines or their precursors. Among compounds reported to precipitate these complications in patients taking MAO inhibitors are tyramine (in beer, wine, cheese, yogurt), 2 amphetamine, 3 methamphetamine, 4 dihydroxyphenylalanine, ie, dopa (in broad beans), 5 and alphamethyl dopa. 6 The following is a report of a patient taking an MAO inhibitor who developed a subarachnoid hemorrhage immediately following the ingestion of one oral dose of ephedrine. A 49-year-old white woman was under treatment for a moderately severe depressive reaction with an MAO inhibitor, nialamide (Niamid), 100 to 150 mg daily since
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
